You are here

Article Text

Article menu
Download PDFPDF
Original Articles: Ovarian Cancer
Notch Signaling Pathway in Ovarian Cancer
  1. Stephen L. Rose, MD
  1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI.
  1. Address correspondence and reprint requests to Stephen L. Rose, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, H4/636, 600 Highland Ave, Madison, WI 53792. E-mail: srose2{at}wisc.edu.

Abstract

The literature is replete with reports of the paradoxical role of Notch signaling in human cancer. Notch appears to act as both an oncogene and a tumor suppressor gene depending on the cellular context. This review focuses on the nascent knowledge of Notch signaling in ovarian cancer. Despite advances in chemotherapy and radical surgery, ovarian cancer remains the most deadly gynecologic malignancy. Therapeutic improvements are necessary to enhance outcomes of patients with ovarian cancer. I will review the evidence for Notch activation in ovarian cancer and potential strategies for Notch inactivation as targeted treatment of ovarian cancer.

  • Ovarian cancer
  • Notch
  • Developmental therapeutics

https://doi.org/10.1111/IGC.0b013e3181a12ed2

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.